Research Directory

Avastin vs Lucentis: the drug reimbursement dilemma of the century

Read more

What lies ahead for AstraZeneca

Read more

A new venture capital model

Read more

Antibodies and ADCs lead cancer pipeline

Read more

New study puts breast cancer into 10 subgroups

Read more

EU pharmacovigilance law comes into force

Read more

Commentary on the impact of pharmacovigilance legislation

Read more

Time to engage with stem-cell therapy

Read more

How tissue plasminogen activator was discovered

Read more

NICE exports its health technology expertise

Read more